Cardalin

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cardalin

Property Description
Active ingredient Nifedipine
Form Oral (Capsules, Tablets, Extended-release Tablets)
Pharmacological class Calcium-channel blocker (Dihydropyridine)
General purpose Vascular relaxation and blood pressure reduction
Origin Synthetic organic compound

What Type of Medicine is Cardalin (Nifedipine)?

Cardalin is a prescription pharmaceutical preparation whose active ingredient is the synthetic organic compound Nifedipine. Pharmacologically, this medicine belongs to the calcium-channel blocker (CCB) class, specifically identified as a dihydropyridine derivative. The core classification of Nifedipine stems from its chemical formula, C17H18N2O6, which defines it as a single-ingredient product designed for oral administration. The drug functions as a direct calcium ion antagonist, meaning its primary function is to directly interfere with the process that causes smooth muscle cells to contract, which is foundational to its therapeutic effects. The specific dihydropyridine structure is associated with high selectivity toward peripheral arterial vasodilation.


Cardalin Forms and General Therapeutic Purpose

The medicine is supplied in various oral dosage forms, including standard capsules and tablets, as well as specialized extended-release tablets such as the GITS formulation. The availability of these different formats is a key feature, allowing for therapeutic flexibility. Functionally, Cardalin’s general purpose is to promote vascular relaxation, which broadly helps to lower high blood pressure and improve oxygen supply to the heart muscle. Nifedipine achieves this by directly inhibiting the influx of calcium ions into the cells of the vascular smooth muscle. This physiological action results in peripheral arterial vasodilation. This process reduces the resistance to blood flow throughout the body, ultimately lessening the work required by the heart to circulate blood efficiently, a principle routinely applied in managing circulatory health.

What side effects are possible with Cardalin?

Possible Side Effects and Safety Information

The medicine Nifedipine (Cardalin) has an officially documented safety profile characterized by adverse reactions classified by frequency and System-Organ Class, as established in regulatory documents (e.g., FDA Prescribing Information and EMA-aligned SmPC). The most frequently reported adverse effects are typically linked to the drug’s vasodilatory action.


Frequency-Classified Adverse Reactions

Adverse reactions are grouped according to their reported occurrence rates:

  • Common (may affect up to 1 in 10 people): Headache, Peripheral Edema (swelling of hands/feet), Flushing, Dizziness, Constipation, Palpitations, and Nausea.
  • Uncommon (may affect up to 1 in 100 people): Hypotension, Syncope (fainting), Vertigo, Tachycardia, and reactions across multiple systems, including Gastrointestinal and Nervous System Disorders.

Serious Adverse Reactions and Safety Constraints

Regulatory labeling highlights clinically significant effects, including reports of Increased Angina or Myocardial Infarction, which have been noted upon the initiation of treatment or with a dose increase. Excessive Hypotension is also documented as a potential concern, particularly when starting treatment.

The medicine is officially contraindicated in patients with conditions such as Cardiogenic Shock, Unstable Angina Pectoris, and High-Grade Aortic Stenosis. Furthermore, the concurrent intake of Grapefruit juice is not recommended due to the potential for increased systemic exposure and adverse effects, as stated in regulatory documents.


Population-Specific Safety Notes

Specific safety considerations are defined for certain populations. Patients with Hepatic Impairment require careful monitoring, as impaired drug clearance can lead to increased systemic exposure. For Older Adults, regulatory documents suggest that lower maintenance doses may be necessary due to potentially higher plasma concentrations compared to younger patients.

Overdose and Emergency Response

Overdose of Cardalin (Nifedipine) is officially documented to present with severe consequences related to its effect on blood circulation. Documented clinical manifestations primarily involve profound hemodynamic instability, including severe hypotension (decreased blood pressure) and irregularities in heart rhythm such as bradycardia or reflex tachycardia. Additional systemic signs noted in regulatory documents include central nervous system effects such as confusion, drowsiness, and delirium, along with findings like hyperglycemia.

Life-threatening outcomes explicitly documented in regulatory information include states of shock, myocardial infarction, asystole, and eventual death resulting from circulatory collapse.

Regulators mandate that individuals seek immediate emergency medical attention and contact emergency services or a poison control center immediately upon suspicion of overdose. This is required due to the potential for rapid deterioration.

The official management protocols are symptomatic and supportive, as no specific antidote is known. Procedures documented in labeling include gastric decontamination (such as activated charcoal), the use of calcium infusions, and vasopressors to restore circulation. Furthermore, continuous cardiac monitoring and a minimum hospital observation period of 12 to 24 hours are required, particularly for patients who have ingested the sustained-release formulations.

Therapeutic Uses of Cardalin

Therapeutic Purpose and Primary Uses

Cardalin is a combination pharmaceutical product formulated to address symptoms associated with chronic respiratory conditions and certain types of pain and fever. It combines two active components: aminophylline and a specific form of salicylate. These ingredients work through different mechanisms to improve respiratory function and provide analgesic effects.

Respiratory Management

The primary therapeutic role of Cardalin is the management of bronchial asthma and other conditions characterized by bronchospasms. The aminophylline component acts as a bronchodilator, helping to relax the smooth muscles of the airways. This action facilitates easier breathing by increasing the diameter of the bronchial tubes, which is particularly beneficial for patients experiencing:

  • Chronic Bronchial Asthma: Helping to reduce the frequency and severity of wheezing and shortness of breath.
  • Bronchitis: Assisting in the management of airway obstruction associated with chronic inflammation of the bronchial tubes.
  • Emphysema: Aiding in the reduction of air trapping and improving airflow in damaged lung tissues.

Analgesic and Anti-inflammatory Benefits

In addition to its respiratory applications, the inclusion of a salicylate derivative provides Cardalin with secondary therapeutic properties. These are primarily utilized to address concurrent symptoms that may arise alongside respiratory distress or as independent indications:

  • Pain Relief: The formulation provides relief for mild to moderate pain, including headaches or musculoskeletal discomfort.
  • Fever Reduction: The salicylate component acts as an antipyretic, helping to lower elevated body temperatures.
  • Anti-inflammatory Action: It helps in reducing localized inflammation, which can contribute to overall systemic comfort in patients with chronic conditions.

Combined Therapeutic Effect

By addressing both airway constriction and systemic symptoms like pain or fever, Cardalin is designed to improve the general quality of life for individuals with complex respiratory needs. The combination aims to stabilize the respiratory environment while mitigating the physical stressors that can often exacerbate breathing difficulties.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who Can and Cannot Use Cardalin?

Cardalin (Nifedipine) eligibility is strictly defined by regulatory documents, allowing its use primarily in the adult population (18 years and older) for labeled indications.

Absolute Contraindications: The medicine is strictly contraindicated in patients with known hypersensitivity to Nifedipine or related dihydropyridines. It must not be used in cases of cardiogenic shock, unstable angina pectoris, or significant aortic stenosis. Use is also prohibited within four weeks of an acute myocardial infarction and during concomitant treatment with the medicine Rifampicin.

Population Restrictions: Use in children and adolescents is not recommended as regulatory bodies have not established safety and efficacy for this group. Older adults may be eligible, but lower maintenance doses and careful monitoring may be required.

Conditional Use: Special caution is mandatory for patients with severe hepatic impairment (liver disease) or pre-existing severe hypotension. Use during pregnancy (especially before 20 weeks) and breastfeeding is generally not recommended unless treatment is deemed essential for severe maternal conditions.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Cardalin (Nifedipine) is structured around its metabolic pathway and pharmacodynamic action, defining specific constraints for co-administration.

Category Documented Interaction Patterns
Formal Contraindications Co-administration with strong CYP3A4 inducers, such as Rifampin, is strictly contraindicated. This combination leads to a severe reduction in Nifedipine plasma concentration and efficacy.
Dietary Restriction Ingestion of Grapefruit and Grapefruit Juice must be avoided. This food-drug interaction is documented to approximately double Nifedipine exposure (AUC and Cmax) via metabolic inhibition.
Metabolic/Exposure Co-administration with CYP3A4 inhibitors (e.g., Azole antifungals, certain Macrolide antibiotics) is documented to increase Nifedipine plasma concentrations. Conversely, moderate inducers like St. John's Wort can reduce exposure.
Pharmacodynamic Combining Cardalin with Beta-blocking agents or other anti-hypertensive medicines may result in additive anti-hypertensive effects (excessive blood pressure lowering).
Transporter-Mediated Nifedipine is documented to affect the levels of co-administered drugs like Digoxin by modulating the P-glycoprotein (P-gp) efflux transporter.
Population Note Nifedipine clearance is documented to be decreased in elderly patients and those with hepatic impairment, leading to higher systemic exposure, which is a key consideration when assessing potential drug interaction risk.

Mechanism of Action

Cardalin exerts its pharmacodynamic action through the antagonism of two distinct receptor types within the sympathetic nervous system.

Firstly, it acts as a beta receptor (beta1 and beta2) antagonist primarily in myocardial tissue. By blocking the binding site of catecholamines (like adrenaline), the drug prevents receptor activation. This interference with the adrenergic signaling cascade modifies early molecular steps that subsequently reduce chronotropy (heart rate) and inotropy (contractile force) of the heart muscle.

Secondly, Cardalin blocks alpha-1 (alpha1) adrenergic receptors located on the smooth muscle cells of peripheral blood vessels. This action prevents the alpha1-mediated signaling that causes muscle contraction. The resulting molecular consequence is the relaxation of vascular smooth muscle, which leads to vasodilation and a subsequent lowering of peripheral vascular resistance.

This simultaneous, dual-receptor antagonism results in a coordinated reduction of sympathetic outflow effects on both the heart and the vasculature, leading to an overall modulation of the cardiovascular system's regulatory activity.

Dosage and Administration Information

How to Use Cardalin

Cardalin is administered exclusively through the oral route, with specific usage patterns dependent on the formulation prescribed. The medicine is available as Immediate-Release (IR) Capsules and various strengths of Extended-Release (ER) Tablets.


Administration Guidelines

Instruction Detail
Route & Form Oral only; available as IR Capsules (e.g., 10 mg, 20 mg) and ER Tablets (e.g., 30 mg, 60 mg, 90 mg).
Frequency Pattern ER Tablets are taken once daily (QD). IR Capsules are taken multiple times daily (typically three to four times a day).
Dosing Adjustment Treatment begins with a starting dose, followed by gradual titration (dose increases) over intervals of typically 7 to 14 days to establish therapeutic levels.
Intake Conditions IR Capsules may be taken regardless of meals. Instructions for some ER Tablets may specify taking the dose on an empty stomach. Administration is generally done with water.
Procedural Restrictions ER Tablets must be swallowed whole. They are strictly not to be crushed, chewed, or split to prevent uncontrolled drug release, a process known as dose dumping.

Usage in Specific Populations

Guidelines exist for management in certain groups. For older adults, the use of the IR capsule formulation is generally advised against. In patients with hepatic impairment (liver issues), dose reduction and careful monitoring may be necessary due to reduced clearance of the drug.

This structured approach to dosing, frequency, and preparation defines the standardized protocol for the long-term use of Cardalin.

Recent Clinical Evidence

Research into the effects of Cardalin, which contains the active ingredient Nifedipine, primarily consists of Randomized Controlled Trials (RCTs) and comprehensive Meta-Analyses. This body of research has been used to study the medicine’s effects on conditions associated with systemic or functional imbalance, specifically high blood pressure and chest pain.


Evidence for use in Essential Hypertension (High Blood Pressure)

Research exploring the effects of the sustained- and extended-release formulations on outcomes related to blood pressure management included evaluation of BP consistency over a full daily cycle. Studies also examined major cardiovascular events as part of its long-term study outcomes, including nonfatal heart attack and stroke. The quality of evidence supporting the evaluation of blood pressure management is categorized as High for the sustained-release formulation. However, long-term effects are not fully established over multiple decades of follow-up.


Evidence for use in Angina Management (Chest Pain)

The research examined Cardalin in patients experiencing chronic stable angina (chest pain associated with exertion) and vasospastic angina (spontaneous artery spasm). Short-term trials monitored patient-reported outcomes describing perceived discomfort and functional measures, such as exercise tolerance. Studies described patterns of changes in the frequency of chest pain observed in the studied populations.

The Importance of Formulation in the Research Record

The research describes a distinction observed between the formulations of Cardalin. Early trial data regarding the immediate-release formulation raised questions about the formulation's profile, while subsequent research on the sustained- or extended-release formulations described different, more consistent patterns.


What Research Gaps and Uncertainties Remain

Studies have explored the durability of response with long-term follow-up periods of one to four years to assess major cardiovascular outcomes. However, a key research limitation is that the results apply only to the populations studied. Research is ongoing to better characterize long-term outcomes and comparative evidence across all potential patient scenarios.

Frequently Asked Questions (FAQ)

Common questions about Cardalin (FAQ)

Q: What is Cardalin used for besides the main condition?

A: According to official product information, Cardalin (Nifedipine) is indicated for treating hypertension (high blood pressure) and chronic stable angina (chest pain). Regulatory documents also note its use in specialized settings, such as for its effects on uterine contraction, though this may not be a primary purpose.

Q: Are there long-term side effects from taking Cardalin for many years?

A: The safety profile documents adverse effects observed in clinical trials, including gingival hyperplasia (gum tissue enlargement), which is a known effect associated with the long-term use of calcium channel blockers. Official information details known effects, such as on liver enzymes, which in some cases have been reported to resolve upon discontinuation of the medicine.

Q: Are there any restrictions on driving or operating machinery while taking Cardalin?

A: Because the medicine can cause drowsiness or dizziness, official patient information includes a warning about mental alertness. The regulatory warning advises that activities requiring full mental alertness, such as driving or operating machinery, may need to be avoided until a patient is aware of how the medicine affects them.

Q: Does Cardalin have a generic equivalent?

A: Yes, the active ingredient in Cardalin is Nifedipine. Nifedipine is available in multiple generic formulations, which are generally expected to contain the same active ingredient and offer the same therapeutic effect.

Q: Is Cardalin used to prevent heart attacks?

A: Cardalin is officially used to manage and control conditions such as high blood pressure and angina. Managing these risk factors is associated with research evaluating major cardiovascular events, including nonfatal heart attack and stroke.

Q: Is Cardalin safe for someone with mild liver issues?

A: Official information states that Nifedipine should be used with caution in patients who have hepatic impairment (liver problems). This is because the body may remove the medicine more slowly, potentially increasing its effects. Official information notes that dose adjustments and careful clinical monitoring may be a consideration in this population.

Q: Are there any skin-related side effects linked to Cardalin?

A: Yes, flushing (redness of the face/neck/upper chest) is a very common documented side effect linked to the drug's action. Other reported skin-related effects include a general rash or itching, and rarely, severe swelling.

Q: Can I take Cardalin if I am currently trying to become pregnant?

A: Use during pregnancy is generally not recommended unless a doctor determines the benefit is essential for a severe maternal condition. The regulatory guidance highlights that women who are pregnant or may become pregnant may require a discussion of risks and precautions with a healthcare professional.

Q: What are the key ingredients in Cardalin?

A: The active ingredient in the medicine is Nifedipine. The medicine also contains various inactive ingredients (excipients), which may include substances like lactose (milk sugar) in some extended-release tablet formulations.

Q: Does Cardalin require any special monitoring?

A: Yes, patients generally require regular checks on their blood pressure to ensure the medicine is working correctly. Additionally, specific populations, such as older adults or those with liver issues, may require closer monitoring by a healthcare professional.

Q: How long does it typically take for Cardalin to start working?

A: The onset of effect depends on the formulation taken. Immediate-release forms of Nifedipine begin working quickly. The extended-release forms, however, provide a gradual effect, and the full therapeutic benefit may take several days or weeks to achieve after the dose is stabilized.

Q: What happens if I miss a dose of Cardalin?

A: Official patient education typically describes two general approaches for a missed dose: taking it as soon as it is remembered, or skipping it if it is near the time for the next scheduled dose. Regulatory information also advises against taking double or extra doses to make up for a missed one.

Q: Can Cardalin affect my sleep?

A: Sleeplessness (insomnia) and unusual drowsiness or sleepiness are reported as potential, though rare, side effects of the drug in the official adverse reactions profile.

Q: Is Cardalin safe to take with common pain relievers like ibuprofen?

A: Official information indicates that common pain relievers classified as NSAIDs (Nonsteroidal Anti-Inflammatory Drugs), such as ibuprofen, may reduce the blood pressure-lowering effect of Nifedipine. The co-administration of the two may be a consideration for closer blood pressure monitoring.

Q: Can Cardalin cause weight gain?

A: Unusual weight gain or loss is reported as a potential side effect in official regulatory documents. Additionally, the drug's action can cause edema (swelling of the lower legs, feet, or arms), which is sometimes mistaken for weight gain.

Q: Can I take Cardalin if I have kidney problems?

A: Official precautions recommend that the medicine should be used with caution in patients with renal impairment (kidney problems). While the removal of Nifedipine from the body is not significantly affected by dialysis, kidney problems may be a consideration for close clinical monitoring.

Q: Does Cardalin interact with supplements like fish oil or magnesium?

A: Nifedipine has reported interactions with certain supplements, notably the herbal remedy St. John's Wort. Information regarding the use of supplements is an area that patients may wish to discuss with their healthcare professional, as some products may have an effect on Nifedipine levels.

Q: Can Cardalin cause hair loss?

A: Hair loss or thinning of the hair (alopecia) is reported as a rare side effect in the regulatory safety labeling for Nifedipine.

Q: What should I do if I get a mild rash while on Cardalin?

A: Rash is a reported side effect of Nifedipine. Regulatory advice indicates that the appearance of a rash is a reason to contact a healthcare professional.

Q: Is it difficult to stop taking Cardalin once I start?

A: Official warnings state that stopping Nifedipine abruptly, particularly after long-term use, is not recommended. Abrupt cessation may lead to rebound hypertension or a worsening of chest pain. Official guidance notes that discontinuation or change in dosage requires the supervision of a healthcare professional.

Q: Can Cardalin make me feel tired or fatigued?

A: Yes, fatigue, weakness, asthenia (lack of physical energy), and general tiredness are all listed as reported side effects of Nifedipine.

Q: Does Cardalin affect blood sugar levels?

A: Official information indicates that Nifedipine has been reported to affect blood sugar regulation in some patients. Information about blood sugar levels is a topic for discussion with a doctor, particularly for patients with diabetes or those monitoring blood sugar.

Q: Is it okay to drink alcohol in moderation while on Cardalin?

A: Alcohol can produce an additive effect in lowering blood pressure when taken with Nifedipine. This combination may increase side effects like headache, dizziness, lightheadedness, and fainting. This potential interaction is a topic for discussion with a healthcare professional.

Q: Can I take cold and flu medicine while taking Cardalin?

A: Regulatory guidance suggests that patients may wish to consult with a healthcare professional before taking over-the-counter cold, cough, or pain medications. Some over-the-counter products, particularly those with decongestants, can increase blood pressure and interfere with the effectiveness of Cardalin.

Q: How long will I likely need to take Cardalin?

A: Nifedipine is a medicine used to control chronic conditions like high blood pressure and chest pain, and it does not offer a cure. Regulatory documents describe that the duration of therapy is determined by a healthcare professional.

Q: Can Cardalin affect my mood or cause depression?

A: Official adverse reaction reports state that mood changes, feelings of discouragement, and feeling sad or empty are reported as rare side effects of Nifedipine.

Q: What happens if I take too much Cardalin by accident?

A: Taking too much Nifedipine is considered an overdose and is a medical emergency. It can cause a severe drop in blood pressure leading to dizziness or fainting, as well as irregular or fast heartbeats and confusion. Suspected overdose is noted as requiring urgent medical attention.

Q: Does taking Cardalin require regular blood tests?

A: The need for blood tests depends on the individual. A doctor may perform tests to make sure the medicine is working and to prevent side effects, especially for patients taking other medications or those with pre-existing conditions like liver impairment.

Q: How long does Cardalin stay in your system after stopping?

A: Official pharmacokinetic data indicates that the elimination half-life of Nifedipine is approximately two hours for the immediate-release form and longer for the extended-release form. The drug is rapidly metabolized, and most of it is quickly excreted from the body as inactive compounds.

Q: Is it normal for Cardalin to cause a dry cough?

A: Cough, difficult or labored breathing, and chest congestion are reported as more common side effects of Nifedipine in regulatory documents.

Q: Can Cardalin interact with caffeine?

A: Caffeine is a stimulant that can potentially raise blood pressure or trigger a fast heartbeat. In some cases, healthcare professionals may consider a reduction in caffeine intake for patients experiencing side effects like palpitations or flushing while taking Nifedipine.

Q: Can Cardalin affect my vision?

A: Vision changes and blurry vision are reported as potential side effects of Nifedipine in the regulatory safety labeling.

How should Cardalin be stored and disposed of?

Cardalin (Nifedipine) must be stored at Controlled Room Temperature, which is generally defined as 15 C to 30 C (59 F to 86 F), or below 30 C.

Environmental and Container Constraints

The product must be protected from light and guarded against excess moisture and humidity. It should be kept in the original container with the cap tightly closed, and it is explicitly stated to keep the medication from freezing. All official labeling mandates storing the product out of the sight and reach of children.

Disposal Instructions

Official disposal of unused or expired Cardalin should be through a Drug Take-Back Program, as recommended by regulatory guidelines. If a take-back program is unavailable, the product must be disposed of safely in household trash by mixing it with an unappealing substance, sealing it in a container, and obscuring personal information on the label. The product should not be allowed to enter sewers or ground water.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cardalin found in:

A-Z Index: